Business Description
GeneFerm Biotechnology Co Ltd
ISIN : TW0001796001
Description
GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.89 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.11 | |||||
| Interest Coverage | 26.16 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.6 | |||||
| Beneish M-Score | -3.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.1 | |||||
| 3-Year EBITDA Growth Rate | 39 | |||||
| 3-Year EPS without NRI Growth Rate | 154 | |||||
| 3-Year Book Growth Rate | 14.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.04 | |||||
| 9-Day RSI | 40.58 | |||||
| 14-Day RSI | 41.04 | |||||
| 6-1 Month Momentum % | -19.67 | |||||
| 12-1 Month Momentum % | -56.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.28 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 120.58 | |||||
| Days Sales Outstanding | 49.39 | |||||
| Days Payable | 7.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.72 | |||||
| Dividend Payout Ratio | 0.73 | |||||
| Forward Dividend Yield % | 2.72 | |||||
| 5-Year Yield-on-Cost % | 2.67 | |||||
| 3-Year Average Share Buyback Ratio | -14.1 | |||||
| Shareholder Yield % | 2.49 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.83 | |||||
| Operating Margin % | 14.42 | |||||
| Net Margin % | 11.79 | |||||
| FCF Margin % | 20.46 | |||||
| ROE % | 10.17 | |||||
| ROA % | 7.07 | |||||
| ROIC % | 8.87 | |||||
| ROC (Joel Greenblatt) % | 12.4 | |||||
| ROCE % | 11.52 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.75 | |||||
| PE Ratio without NRI | 26.72 | |||||
| Shiller PE Ratio | 38.89 | |||||
| Price-to-Owner-Earnings | 22.24 | |||||
| PEG Ratio | 0.63 | |||||
| PS Ratio | 3.15 | |||||
| PB Ratio | 2.85 | |||||
| Price-to-Tangible-Book | 2.86 | |||||
| Price-to-Free-Cash-Flow | 15.38 | |||||
| Price-to-Operating-Cash-Flow | 11.62 | |||||
| EV-to-EBIT | 20.64 | |||||
| EV-to-EBITDA | 12.26 | |||||
| EV-to-Revenue | 3.17 | |||||
| EV-to-FCF | 15.49 | |||||
| Price-to-Projected-FCF | 5.08 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.07 | |||||
| Price-to-Graham-Number | 1.84 | |||||
| Price-to-Net-Current-Asset-Value | 72.5 | |||||
| Earnings Yield (Greenblatt) % | 4.84 | |||||
| FCF Yield % | 6.52 | |||||
| Forward Rate of Return (Yacktman) % | 18.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeneFerm Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 728.393 | ||
| EPS (TTM) (NT$) | 2.06 | ||
| Beta | 0.3 | ||
| Volatility % | 32.73 | ||
| 14-Day RSI | 41.04 | ||
| 14-Day ATR (NT$) | 1.545489 | ||
| 20-Day SMA (NT$) | 56.095 | ||
| 12-1 Month Momentum % | -56.9 | ||
| 52-Week Range (NT$) | 53.6 - 158.5 | ||
| Shares Outstanding (Mil) | 41.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GeneFerm Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GeneFerm Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
GeneFerm Biotechnology Co Ltd Frequently Asked Questions
What is GeneFerm Biotechnology Co Ltd(ROCO:1796)'s stock price today?
The current price of ROCO:1796 is NT$55.10. The 52 week high of ROCO:1796 is NT$158.50 and 52 week low is NT$53.60.
When is next earnings date of GeneFerm Biotechnology Co Ltd(ROCO:1796)?
The next earnings date of GeneFerm Biotechnology Co Ltd(ROCO:1796) is .
Does GeneFerm Biotechnology Co Ltd(ROCO:1796) pay dividends? If so, how much?
The Dividend Yield %  of GeneFerm Biotechnology Co Ltd(ROCO:1796) is 2.72% (As of Today), Highest Dividend Payout Ratio of GeneFerm Biotechnology Co Ltd(ROCO:1796) was 2.62. The lowest was 0.06. And the median was 0.5. The  Forward Dividend Yield % of GeneFerm Biotechnology Co Ltd(ROCO:1796) is 2.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers